Navigation Links
Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
Date:11/3/2011

SAN DIEGO, Nov. 3, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $13.6 million for the third quarter of 2011, an increase of 16% compared to revenues of $11.7 million for the third quarter of 2010.  Net loss for the third quarter of 2011 was $18.4 million or $0.19 per share, as compared to net loss of $22.7 million, or $0.30 per share for the same period in 2010.

Gross margin for the third quarter of 2011 was 60% of revenue as compared to gross margin of 65% for the third quarter of 2010.  This difference reflects a change in the mix of product sales in the genetic analysis segment as well as the increased proportion of molecular diagnostics segment revenues, which were recognized on a cash basis with lower margins.

Total operating expenses for the third quarter were $26.4 million, as compared to total operating expenses of $30.5 million for the third quarter of 2010.  This reduction was primarily the result of a decrease in litigation settlement expense of $7.0 million for the third quarter of 2010, which did not recur in 2011.  Research and development expenses increased by $1.3 million to $12.6 million for the third quarter of 2011, a change associated primarily with expansion of the Sequenom Center for Molecular Medicine (Sequenom CMM) laboratory and pre-launch development activities for the MaterniT21 laboratory developed test (LDT).  Selling and marketing expenses increased by $1.4 million to $8.3 million for the third quarter of 2011, resulting primarily from higher labor costs associated with the expansion of the diagnostic sales force.  Total stock-based compensation expense was $3.1 million for the third quarter of 2011, an increase from the $2.8 million recorded for the third quarter of 2010.

"Results for the q
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Sequenom, Inc. Announces Date of Second Quarter 2011 Financial Results and Conference Call
2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
3. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
4. Par Pharmaceutical Reports Second Quarter 2008 Results
5. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
6. Pharmos Corporation Reports 2008 Second Quarter Results
7. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
9. BMP Sunstone Reports Second Quarter 2008 Financial Results
10. ULURU Inc. Reports Second Quarter 2008 Financial Results
11. Immtech Reports Fiscal First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... 25, 2013 Significant research in quantum ... been recognized with presentation of awards by the ... made 16 April during the SPIE Optics and Optoelectronics ... for optics and photonics , is an International Society ... University was presented with the 2011 ICO Galileo Galilei ...
(Date:5/25/2013)... Dennis R. HIll M.D. Radiation Oncologist at ... that recently there has been a promotion of the idea ... permanent seed, or low dose rate, brachytherapy for prostate cancer. ... energy, a shorter half life, and gives a higher biologically ... 131 has a higher average energy than the other commonly ...
(Date:5/24/2013)... Dr. Ingrid Warmuth and Anamaria Newport, MHS, PA-C, with ... announce an Open House at their Swedesboro location, 95 Woodstown ... from 10 AM to 2 PM. , During the ... will be on hand to talk to people about the ... complimentary cosmetic consultations. There will also be specials offered, such ...
(Date:5/24/2013)... WA (PRWEB) May 24, 2013 ... engineers, and industry suppliers will present technologies with ... at the annual SPIE Optics and Photonics ... Organized by SPIE, the international society for ... largest international, multidisciplinary optical sciences and technology meeting ...
Breaking Biology Technology:ICO Honors Three with Awards during SPIE Optics and Optoelectronics 2ICO Honors Three with Awards during SPIE Optics and Optoelectronics 3Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4
... Mass. and CLEARWATER, Fla., Sept. 10 ... whole blood analyzers, and CCS Medical, Inc. a leading ... have reached a definitive agreement under which Nova Biomedical,s ... certain assets of Sanvita, Inc., a wholly-owned subsidiary of ...
... , , HOUSTON, ... a provider agreement with Beech Street Corporation, one of the ... Beech Street will assist SpectraCell with the ever-increasing administrative needs ... , , Beech Street addresses the ...
... , , HORSHAM, Pa., ... today announced that it received a Complete Response letter from ... Drug Application (NDA) for trabectedin when administered in combination with ... the treatment of women with relapsed ovarian cancer. The ...
Cached Biology Technology:Nova Biomedical and CCS Medical Reach Definitive Agreement for a Subsidiary of Nova Biomedical to Acquire Assets of CCS Medical's Subsidiary, Sanvita Inc. 2Nova Biomedical and CCS Medical Reach Definitive Agreement for a Subsidiary of Nova Biomedical to Acquire Assets of CCS Medical's Subsidiary, Sanvita Inc. 3SpectraCell Contracts With Beech Street Corporation 2FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 2
(Date:5/24/2013)... Studying complex systems like ecosystems can get messy, especially ... big unknowns like climate change. , In a ... Proceedings of the National Academy of Sciences , ... a fundamental assumption at the very heart of a ... To model how climate changes may impact biodiversity, researchers ...
(Date:5/24/2013)... frequently expressed concern in the ongoing public health debate ... those that are nutrient dense. A new study, ... Most Nutrients Per Penny," published in the journal ... the best nutritional values in the produce aisle, providing ... most other raw vegetables and delivering one of the ...
(Date:5/24/2013)... of the world,s largest and fastest growing open-access publishers, ... Frontiers in Physics . , A broad scope journal ... provide an open-science and interactive web platform for the ... articles. , Frontiers, real-time and interactive peer-review enables ... article types. With an average of three months from ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... Salts Emerging as New Recreational Drugs, (#1120069, Wednesday, ... bath salts as recreational drugs has greatly escalated in ... Sciences Center in Oklahoma City, Oklahoma describe an incident ... who also exhibited violent behavior upon his emergency department ...
... Exposure in the womb to bisphenol A (BPA) ... other consumer goods is associated with behavior and ... led by researchers at Harvard School of Public Health ... Fraser University in Vancouver, British Columbia. BPA ...
... identifying ideal drug combinations from billions of others which ... in Nature Chemical Biology , could be the ... to combat severe diseases and conditions. Most non-infectious ... by inflammation, which is the body,s natural defence mechanism. ...
Cached Biology News:CHEST 2011: Embargoed studies highlight new lung health research 2CHEST 2011: Embargoed studies highlight new lung health research 3CHEST 2011: Embargoed studies highlight new lung health research 4CHEST 2011: Embargoed studies highlight new lung health research 5CHEST 2011: Embargoed studies highlight new lung health research 6Exposure to chemical BPA before birth linked to behavioral, emotional difficulties in girls 2Manchester's 'first step' to perfect drug combinations 2
... NOS assay kit measures NOS activity by ... citrulline. This assay is simple, sensitive, and ... used with both crude and purified enzyme ... reagents for 50 total reactions. Radiolabeled arginine ...
Human Complement Component C5a MAb (Clone 295003)...
Human OSCAR MAb (Clone 259501)...
Homo sapiens retinoid X receptor, alpha...
Biology Products: